tradingkey.logo
tradingkey.logo
Search

Becton Dickinson and Co

BDX
Add to Watchlist
140.710USD
-3.270-2.27%
Close 06/22, 16:00ETQuotes delayed by 15 min
38.77BMarket Cap
35.45P/E TTM

Becton Dickinson and Co

140.710
-3.270-2.27%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-2.27%

5 Days

-3.31%

1 Month

-4.69%

6 Months

-8.99%

Year to Date

-7.74%

1 Year

+6.31%

Key Figures
142.380Open
143.359High
3.64MVolume
35.45P/E TTM
10.46P/E Dynamic
4.180Dividend TTM
1.32%Turnover Ratio
143.980Prev. Close
140.110Low
250.84MTurnover
23.11P/E Static
1.61P/B
2.97%Div Yield TTM
3.13%ROA
187.35052wk High
1.27Volume Ratio
1.68BNet Profit
275.54MShares
3.9693EPS TTM
0.23Beta
6.67%ROE
127.53652wk Low
2.26%Amplitude
46.58%Gross Margin
38.77BMarket Cap
-1.07Reward/Risk
1.45%Risk Rate

Key Insights

Becton Dickinson and Co's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 63 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 183.44.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Becton Dickinson and Co's Score

Industry at a Glance

Industry Ranking
63 / 203
Overall Ranking
177 / 4577
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative-

Becton Dickinson and Co Highlights

StrengthsRisks
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 21.84B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 71.28%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 71.28%.
Fairly Valued
The company’s latest PE is 35.45, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 241.06M shares, decreasing 16.25% quarter-over-quarter.
Held by First Pacific Advisors
Star Investor First Pacific Advisors holds 2.11M shares of this stock.

Analyst Rating

Based on 17 analysts
Buy
Current Rating
183.436
Target Price
+27.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Becton Dickinson and Co News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Becton Dickinson and Co Info

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Ticker SymbolBDX
CompanyBecton Dickinson and Co
CEOPolen (Thomas E)
Websitehttps://www.bd.com/

FAQs

What is the current price of Becton Dickinson and Co (BDX)?

The current price of Becton Dickinson and Co (BDX) is 140.71.

What is the symbol of Becton Dickinson and Co?

The ticker symbol of Becton Dickinson and Co is BDX.

What is the 52-week high of Becton Dickinson and Co?

The 52-week high of Becton Dickinson and Co is 187.35.

What is the 52-week low of Becton Dickinson and Co?

The 52-week low of Becton Dickinson and Co is 127.54.

What is the market capitalization of Becton Dickinson and Co?

The market capitalization of Becton Dickinson and Co is 38.77B.

Is Becton Dickinson and Co (BDX) currently rated as Buy, Hold, or Sell?

According to analysts, Becton Dickinson and Co (BDX) has an overall rating of Buy, with a price target of 183.44.

What is the Earnings Per Share (EPS TTM) of Becton Dickinson and Co (BDX)?

The Earnings Per Share (EPS TTM) of Becton Dickinson and Co (BDX) is 5.83.
KeyAI